{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:07:25Z","timestamp":1790647645329,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijid.2019.10.016","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T11:20:12Z","timestamp":1571484012000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-1495","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-7037","authenticated-orcid":false,"given":"Treasure M.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-5663","authenticated-orcid":false,"given":"Samantha A.","family":"Hollingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1573-9601","authenticated-orcid":false,"given":"Yalin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-9553","authenticated-orcid":false,"given":"Mieke L.","family":"Van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijid.2019.10.016_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/1040841X.2011.645521","article-title":"A practical critique of antifungal treatment guidelines for haemato-oncologists","volume":"38","author":"Agrawal","year":"2012","journal-title":"Crit Rev Microbiol"},{"issue":"5","key":"10.1016\/j.ijid.2019.10.016_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.eimc.2011.01.008","article-title":"Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update","volume":"29","author":"Aguado","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jiph.2013.08.002","article-title":"Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: expert panel recommendations","volume":"7","author":"Alothman","year":"2014","journal-title":"J Infect Public Health"},{"issue":"Suppl_3","key":"10.1016\/j.ijid.2019.10.016_bib0020","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2466\/pr0.1966.19.1.3","article-title":"The intraclass correlation coefficient as a measure of reliability","volume":"19","author":"Bartko","year":"1966","journal-title":"Psychol Rep"},{"issue":"12","key":"10.1016\/j.ijid.2019.10.016_bib0030","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"issue":"7156","key":"10.1016\/j.ijid.2019.10.016_bib0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/bmj.317.7156.465","article-title":"Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane effective practice and organization of care review group","volume":"317","author":"Bero","year":"1998","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0040","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"5","key":"10.1016\/j.ijid.2019.10.016_bib0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"Brouwers","year":"2010","journal-title":"Prev Med"},{"issue":"10","key":"10.1016\/j.ijid.2019.10.016_bib0050","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1503\/cmaj.091716","article-title":"Development of the AGREE II, part 2: assessment of validity of items and tools to support application","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"11","key":"10.1016\/j.ijid.2019.10.016_bib0055","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2337\/diacare.25.11.1933","article-title":"Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries","volume":"25","author":"Burgers","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-016-1313-6","article-title":"Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy","volume":"20","author":"Calandra","year":"2016","journal-title":"Crit Care"},{"issue":"12b","key":"10.1016\/j.ijid.2019.10.016_bib0065","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/imj.12597","article-title":"Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014","volume":"44","author":"Chen","year":"2014","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.ijid.2019.10.016_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","article-title":"Brazilian guidelines for the management of candidiasis \u2014 a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical","volume":"17","author":"Colombo","year":"2013","journal-title":"Braz J Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.ijid.2019.10.016_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0080","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","author":"Cortegiani","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13054-016-1521-0","article-title":"Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?","volume":"20","author":"Cortegiani","year":"2016","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.ijid.2019.10.016_bib0090","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00134-005-2794-y","article-title":"Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis","volume":"31","author":"Cruciani","year":"2005","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2013.06.005","article-title":"Candidaemia in the non-neutropenic patient: a critique of the guidelines","volume":"42","author":"Deshpande","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.ijid.2019.10.016_bib0100","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/j.1875-9114.2012.01124","article-title":"Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options","volume":"32","author":"Dodds Ashley","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"9156","key":"10.1016\/j.ijid.2019.10.016_bib0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(98)07516-3","article-title":"Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer","volume":"353","author":"Eisinger","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5492\/wjccm.v3.i4.102","article-title":"Invasive Candidiasis in critical care setting, updated recommendations from \u201cInvasive Fungal Infections-Clinical Forum\u201d, Iran","volume":"3","author":"Elhoufi","year":"2014","journal-title":"World J Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/M16-2020","article-title":"The scientific basis of guideline recommendations on sugar intake: a systematic review","volume":"166","author":"Erickson","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0120","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/dks482","article-title":"Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study","volume":"68","author":"Eschenauer","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"7049","key":"10.1016\/j.ijid.2019.10.016_bib0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.313.7049.93","article-title":"What constitutes controlled hypertension? Patient based comparison of hypertension guidelines","volume":"313","author":"Fahey","year":"1996","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ijid.2019.10.016_bib0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis","volume":"58","author":"Fernandez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001363","article-title":"The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis","volume":"10","author":"Free","year":"2013","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.ijid.2019.10.016_bib0140","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.clnu.2016.03.005","article-title":"Nutrition in critically ill adults: a systematic quality assessment of clinical practice guidelines","volume":"35","author":"Fuentes Padilla","year":"2016","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ijid.2019.10.016_bib0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2017.06.028","article-title":"Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument","volume":"67","author":"Gavriilidis","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ijid.2019.10.016_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00134-008-1339-6","article-title":"Management of invasive Candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part II. Treatment","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"issue":"7650","key":"10.1016\/j.ijid.2019.10.016_bib0155","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ijid.2019.10.016_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3314\/mmj.54.147","article-title":"JSMM clinical practice guidelines for diagnosis and treatment of invasive candidiasis","volume":"54","author":"JSMM","year":"2013","journal-title":"Med Mycol J"},{"issue":"11","key":"10.1016\/j.ijid.2019.10.016_bib0165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/cid\/civ707","article-title":"A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections","volume":"61","author":"Knitsch","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0170","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.3314\/mmj.16-00010","article-title":"Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014","volume":"57","author":"Kohno","year":"2016","journal-title":"Med Mycol J"},{"issue":"12","key":"10.1016\/j.ijid.2019.10.016_bib0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.10.016_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmii.2017.07.006","article-title":"2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan","volume":"51","author":"Kung","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.ijid.2019.10.016_bib0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Leon","year":"2006","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2019.10.016_bib0190","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/1469-0691.12426","article-title":"Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal","volume":"19","author":"Leroux","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijid.2019.10.016_bib0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bjsports-2017-098375","article-title":"Poor overall quality of clinical practice guidelines for musculoskeletal pain: a systematic review","volume":"52","author":"Lin","year":"2018","journal-title":"Br J Sports Med"},{"issue":"9","key":"10.1016\/j.ijid.2019.10.016_bib0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ijid.2019.10.016_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/2321-3868.130182","article-title":"Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013","volume":"2","author":"Luo","year":"2014","journal-title":"Burns Trauma"},{"key":"10.1016\/j.ijid.2019.10.016_bib0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ctrv.2018.03.001","article-title":"Quality assessment of clinical practice guidelines on treatments for oral cancer","volume":"65","author":"Madera Anaya","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anrea.2014.12.006","article-title":"Guidelines for management of intra-abdominal infections","volume":"1","author":"Montravers","year":"2015","journal-title":"Anesthesie et Reanimation"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0225","first-page":"221","article-title":"Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology","volume":"25","author":"Morgan","year":"2017","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.ijid.2019.10.016_bib0230","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2019.10.016_bib0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"Ostrosky-Zeichner","year":"2011","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.ijid.2019.10.016_bib0240","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0245","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.10.016_bib0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","article-title":"Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0255","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"10.1016\/j.ijid.2019.10.016_bib0260","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.10.016_bib0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1439-0507.2011.02040.x","article-title":"Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy","volume":"54","author":"Ruhnke","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2019.10.016_bib0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2016.07.007","article-title":"MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management","volume":"34","author":"Scudeller","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ijid.2019.10.016_bib0275","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s15010-013-0558-0","article-title":"An Italian consensus for invasive candidiasis management (ITALIC)","volume":"42","author":"Scudeller","year":"2014","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.ijid.2019.10.016_bib0280","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000178352.14703.49","article-title":"Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis","volume":"33","author":"Shorr","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2019.10.016_bib0285","doi-asserted-by":"crossref","first-page":"i5191","DOI":"10.1136\/bmj.i5191","article-title":"Introduction to BMJ Rapid Recommendations","volume":"354","author":"Siemieniuk","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ijid.2019.10.016_bib0290","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2019.10.016_bib0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"21","key":"10.1016\/j.ijid.2019.10.016_bib0300","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ijid.2019.10.016_bib0305","doi-asserted-by":"crossref","first-page":"e00620","DOI":"10.1128\/AAC.00620-17","article-title":"Choosing optimal antifungal agents to prevent fungal infections in nonneutropenic critically ill patients: trial sequential analysis, network meta-analysis, and pharmacoeconomic analysis","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2019.10.016_bib0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.10.016_bib0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.riam.2014.06.001","article-title":"EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations","volume":"31","author":"Zaragoza","year":"2014","journal-title":"Rev Iberoam Micol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219304096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219304096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:47:42Z","timestamp":1761119262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219304096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":63,"alternative-id":["S1201971219304096"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.10.016","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}